2019
DOI: 10.3390/molecules24071252
|View full text |Cite
|
Sign up to set email alerts
|

3-Hydroxyflavones and 3-Hydroxy-4-oxoquinolines as Carbon Monoxide-Releasing Molecules

Abstract: Carbon monoxide-releasing molecules (CORMs) that enable the delivery of controlled amounts of CO are of strong current interest for applications in biological systems. In this review, we examine the various conditions under which CO is released from 3-hydroxyflavones and 3-hydroxy-4-oxoquinolines to advance the understanding of how these molecules, or derivatives thereof, may be developed as CORMs. Enzymatic pathways from quercetin dioxygenases and 3-hydroxy-4-oxoquinoline dioxygenases leading to CO release ar… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
36
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 39 publications
(36 citation statements)
references
References 126 publications
0
36
0
Order By: Relevance
“…9-(Diethylamino)-3-methoxy-5H-benzo[a]phenoxazin-5-one (15). The compound was synthesized according to a literature procedure.…”
Section: ■ Experimental Sectionmentioning
confidence: 99%
See 1 more Smart Citation
“…9-(Diethylamino)-3-methoxy-5H-benzo[a]phenoxazin-5-one (15). The compound was synthesized according to a literature procedure.…”
Section: ■ Experimental Sectionmentioning
confidence: 99%
“…It has been evidenced that CO is biologically relevant; it exhibits antiapoptotic, anti-inflammatory, antiproliferative, and anticoagulation effects and prevention of tissue damage and cardiovascular pathology, although the mechanisms are still not well understood. To utilize these potentially chemopreventive and/or therapeutic effects, CO-releasing molecules (CORMs) have been developed as artificial tools to deliver therapeutic amounts of CO into the cell using various initiation approaches. , …”
Section: Introductionmentioning
confidence: 99%
“…11,14 Rational design of such photoactivatable CORMs (photoCORMs), based on, for example, xanthene 14 or BODIPY moieties, 40 allowed for fine-tuning of their optical and chemical properties. The bathochromic shift of absorption spectra toward the visible and nearinfrared region (i.e., a phototherapeutic window), [41][42][43] is especially important for bioapplications. The potential therapeutic use of photoCORMs depends on the same legal and economic considerations as for other drugs.…”
Section: Introductionmentioning
confidence: 99%
“…One key obstacle in developing CO‐based therapeutics is the difficulty in its controlled delivery because inhalation of gaseous CO does not allow easy control of quantity and risk factors 134,135 . Therefore, there has been much interest in developing CO‐releasing molecules (CO‐RMs) 135–137 and recently CO prodrugs for controlled delivery via oral or parenteral administration 124,138 . Aiming for developing controlled CO delivery methods, an enrichment‐triggered method was used to target the mitochondrion, which is the site of action for CO.…”
Section: Enrichment‐triggered Drug Releasementioning
confidence: 99%